Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Systemic Lupus Erythematosus
NCT04736953Phase 2Not yet recruiting
- Sponsor
- Upstate Medical University
- Start
- Jan 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sirolimus in systemic lupus erythematosus (SLE), sponsored by Upstate Medical University. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04736953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04736953.